ECHO Elimination of Cervical Cancer in Latin America (ECHO ELA): Lessons Learned From Promoting WHO’s Cervical Cancer Elimination Goals ‘90-70-90’

Author:

Varon Melissa Lopez1,Salcedo Mila Pontremoli1,Schmeler Kathleen1,San Miguel-Majors Sandra2,Trimble Edward L.2,Lowy Doug2,Arrossi Silvina3,Tereza da Costa Oliveira Maria4,Maza Mauricio5,Montealegre Jane6,Helena de Oliveira Lucia4,Benitez-Majano Sara4,Luciani Silvana3

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX

2. National Cancer Institute, Rockville, MD

3. Instituto Nacional de Cancer de Argentina, Buenos Aires, Argentina

4. PAHO/WHO, Washington, DC

5. Basic Health International, San Salvador, El Salvador and New York, NY

6. Baylor College of Medicine, Houston, TX

Abstract

PURPOSE Cervical cancer (CC) is one of the leading causes of cancer deaths among women in some countries in the Region of the Americas.1 CC is preventable through HPV vaccination, screening and treatment of precancerous lesions, and can be effectively treated if diagnosed early. METHODS Under the framework of the Global Strategy to Accelerate the Elimination of CC as a Public Health Problem, The University of Texas MD Anderson Cancer Center (MD Anderson), the US National Cancer Institute (NCI), and the Pan American Health Organization (PAHO) partnered to develop the Project ECHO for the elimination of CC in Latin America (ECHO ELA). ECHO ELA is modeled on Project ECHO® (Extension of Community Healthcare Outcomes) a hub-and-spoke knowledge-sharing approach where expert teams lead virtual didactic lectures and case discussions, building capacity for participants to deliver best-practice programs to their regions.3 ECHO ELA consists of monthly, Spanish telementoring conferences to assist Latin American (LA) countries reaching the WHO CC elimination goals “90-70-90:” vaccinating 90% of girls against HPV by the age of 15, screening 70% of women for cervical cancer at ages 35 and 45 and treating 90% of women diagnosed with pre-invasive disease or cervical cancer. Program targets professionals from Ministries of Health, including Immunization and Screening Program Managers, and cervical cancer stakeholders. RESULTS In the first year of the program (2020-2021), 294 participants from 22 countries were registered. Fourteen sessions were held averaging 77 participants per session on topics spanning comprehensive program planning, presenting country experiences on HPV vaccination strategies, new technologies for screening and treatment. Eighteen participants completed the post survey addressing priorities, capacity, and desired outcomes, and two focus groups collected facilitators/barriers to achieving goals. CONCLUSION ECHO ELA is potentially an effective tool to enhance collaboration and support countries’ progress towards the elimination of CC.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3